IndieBio Revenue and Competitors
Estimated Revenue & Valuation
- IndieBio's estimated annual revenue is currently $9.3M per year.
- IndieBio's estimated revenue per employee is $155,000
Employee Data
- IndieBio has 60 Employees.
- IndieBio grew their employee count by 9% last year.
IndieBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Managing Director and Founder. General Partner | Reveal Email/Phone |
2 | scientific Director & partner | Reveal Email/Phone |
3 | principal | Reveal Email/Phone |
4 | program dir & partner | Reveal Email/Phone |
5 | strategy dir | Reveal Email/Phone |
IndieBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is IndieBio?
We are the world's leading biotech accelerator, we fund and accelerate 30 biotech startups per year. - We provide global scientists and entrepreneurs with a $250k package that includes a lab and co-working space in down town SF
keywords:N/AN/A
Total Funding
60
Number of Employees
$9.3M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IndieBio News
One of these companies is CellCrine, which claims to be developing the world's cheapest serum-free growth media. As a member of IndieBio's 12th...
In California, IndieBio San Francisco's 12th batch is debuting on April 26 at 10 am PST (virtual). The presentation will be less than 45...
At both SOSV and IndieBio, Wu is responsible for portfolio management and technical oversight. She's focused on funding early-stage climate...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 60 | -30% | N/A |
#2 | $6.5M | 60 | 5% | N/A |
#3 | $13.1M | 60 | -12% | N/A |
#4 | $7.8M | 60 | 9% | N/A |
#5 | $6.8M | 60 | -19% | $10M |